Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 04/11/2019

Funding Opportunity Announcements (FOAs)

Funding Opportunities through DCTD’s Programs

Visit the websites of DCTD's individual programs for more information on currently available funding opportunities.

DCTD-related Cancer Moonshot Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (Clinical Trial Not Allowed) RFA-CA-19-044 March 25,
2019
April 26,
2019
U01
Gene Fusions in Pediatric Sarcomas PA-16-251 September 15, 2017 May 8, 2019 R01
Gene Fusions in Pediatric Sarcomas PA-16-252 September 16, 2017 May 8, 2019 R21
Notice of Special Interest: Administrative Supplements to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN) NOT-CA-19-032 March 15, 2019 July 1, 2019 Admin Supp
Trans-DCTD Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
NCI Clinical and Translational Exploratory/Developmental Studies (Clinical Trial Optional) PAR-18-020 January 20,
2018
March 23,
2019
R21
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (Clinical Trial Required) PAR-18-011 January 15,
2018
February 15,
2020
R01
DCTD-related Trans-NCI Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Revision Applications for Validation of Biomarker Assays Developed through NIH-Supported Research Grants PAR-17-003 January 28,
2017
October 29,
2019
R01
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) PAR-18-317
PAR-18-310
January 14,
2018
October 9,
2020
UH2/UH3
UH3
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (Clinical Trial Optional) RFA-CA-19-034 May 19,
2019
October 19,
2020
P20
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (Clinical Trial Required) PAR-18-560 February 15,
2018
January 8,
2021
R01
Academic Research Enhancement Award (Clinical Trial Required) PA-18-343 January 25, 2018 January 8, 2021 R15
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) PAR-19-193 May 16, 2019 May 8, 2022 R01
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) PAR-19-194 May 16, 2019 May 8, 2022 R21
DCTD-related Trans-NIH Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Mechanisms and Consequences of Sleep Disparities in the U.S. PAR-17-234 June 11,
2017
July 12,
2019
R01
Mechanisms and Consequences of Sleep Disparities in the U.S. PAR-17-235 June 11,
2017
July 12,
2019
R21
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (Clinical Trial Not Allowed) PAR-18-733 May 16,
2018
September 8,
2019
R03
Serious Adverse Drug Reaction Research PAR-16-274
PAR-16-275
September 4,
2016
September 8,
2019
R21
R01
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (Clinical Trial Optional) PAR-18-009 November 1,
2017
November 6,
2019
R01
Assay Development and Screening for Discovery of Chemical Probes or Therapeutic Agents PAR-17-438 September 5,
2017
September 8,
2020
R01
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (Clinical Trial Optional) PAR-18-530 February 28,
2018
January 8,
2021
R01
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (Clinical Trial Optional) PA-18-738 May 5,
2018
May 8,
2021
R01
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (Clinical Trial Optional) PA-18-739 May 16,
2018
May 8,
2021
R21
Bioengineering Research Grants (BRG) (Clinical Trial Required) PAR-19-159 January 8,
2019
May 8,
2021
R01
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (Clinical Trial Optional) PA-18-902 September 5,
2018
September 8,
2021
R01
Bioengineering Research Grants (BRG) (Clinical Trial Not Allowed) PAR-19-158 January 8,
2019
January 8,
2022
R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Not Allowed) PAR-19-149 January 16,
2019
January 8,
2022
R21
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Optional) PAR-19-150 January 16,
2019
January 8,
2022
R21